EN
HI
Summary
As of 15 Sep, 2026, Gennex Laboratories stock price is ₹11.1. During the trading session, the stock has moved between an intraday low of ₹10.68 and an intraday high of ₹11.44. Over the last 52 weeks, Gennex Laboratories has traded between ₹7.05 and ₹17.25.
The stock has recorded a trading volume of 1,78,565 shares,. Its Average Traded Price (ATP) is ₹10.96, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 50 @ ₹11.10.
Gennex Laboratories has an upper circuit limit of ₹13.24 and a lower circuit limit of ₹8.84. The total value traded stands at ₹19.57 L, and the delivery percentage for the day is 80.11%.
The stock is currently traded with a market lot size of 1. Gennex Laboratories also offers a dividend yield of 0%.
Gennex Laboratories Share Price Chart
Gennex Laboratories Share Key Metrics
Volume
1.79 L
Market Cap
268.21 CR
LTQ@LTP
50@11.10
ATP
10.96
Var Margin
50 %
Circuit Range
8.84-13.24
Delivery %
80.11 %
Value
19.57 L
ASM/GSM
No
Market Lot
1
Gennex Laboratories Fundamentals
P/E Ratio
13.83
P/B Ratio
1.18
Div. Yield
0
Sector P/E
41.67
Sector P/B
3.6
Sec. Div. Yield
0.51
Gennex Laboratories Resistance and Support
Pivot 11.05
Resistance
First Resistance
11.42
Second Resistance
11.81
Third Resistance
12.18
Support
First Support
10.66
Second Support
10.29
Third Support
9.9
Gennex Laboratories Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Sep 11 2026 | 11.21 | 11.03 | -1.61% | 11.43 | 10.68 |
| Thu Sep 10 2026 | 11.43 | 11.21 | -1.92% | 11.75 | 11.11 |
| Wed Sep 09 2026 | 11.69 | 11.43 | -0.35% | 11.86 | 11.35 |
Gennex Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-09-04 | A.G.M. |
| 2026-08-14 | Quarterly Results |
| 2026-05-30 | Audited Results |
| 2026-04-16 | Others |
| 2026-02-14 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-09-04 | A.G.M. |
| 2025-08-14 | Quarterly Results |
| 2025-05-30 | Audited Results |
| 2025-02-14 | Quarterly Results |
| 2024-11-14 | Quarterly Results & Others |
| 2024-08-14 | Quarterly Results |
Gennex Laboratories News
Gennex Laboratories Ltd - 531739 - Approval Of Additional Products From Drugs Control Administration, Government Of Andhra Pradesh For Our Subsidiary Company, Deccan Remedies Limited
Gennex Laboratories' subsidiary, Deccan Remedies Limited, has received approval from the Andhra Pradesh Drug Control Administration to manufacture 6 new products and obtained test licenses for 4 drugs. These approvals enhance the subsidiary's product portfolio for both domestic and export markets.
Sep 08 2026 17:37:09
Gennex Laboratories Management
| Name | Position |
|---|---|
| Dinesh Kumar Kejriwal | Company Secretary & Compliance Officer |
| Arihant Baid | Managing Director |
Gennex Laboratories Similar Stocks
Coral Laboratories Ltd.
585.00
0.00 (0.00%)
Astonea Labs Ltd.
289.00
0.00 (0.00%)
Lyka Labs Ltd.
82.51
0.00 (0.00%)
Panchsheel Organics Ltd.
109.00
0.00 (0.00%)
Zenotech Laboratories Ltd.
44.50
-0.48 (1.07%)
Aashka Hospitals Ltd.
84.98
0.00 (0.00%)
Kimia Biosciences Ltd.
27.24
-0.37 (1.34%)
Kerala Ayurveda Ltd.
173.65
-0.55 (0.32%)
Nectar Lifesciences Ltd.
11.74
0.24 (2.09%)
Gennex Laboratories FAQs
The Buying Price of Gennex Laboratories share is 11.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Gennex Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Gennex Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Gennex Laboratories shares is 13.83. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Gennex Laboratories shares is 1.18. Useful to assess the stock's value relative to its book value.
To assess Gennex Laboratories’s valuation compare Sector P/E, P/B which are 41.67 & 3.6 with sector averages, along with growth rates and financial metrics.
The Market Cap of Gennex Laboratories is 268.21 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Gennex Laboratories share price is 17.25 & 7.05. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Gennex Laboratories belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in GENNEX
